Teva expects sales injection from U.S. EpiPen market

Teva Pharmaceutical Industries expects its generic version of Mylan's EpiPe...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Teva expects about 25 percent of EpiPen market by year-endTeva Pharmaceutical Industries expects its generic version of Mylan's EpiPe...
Read more »

Stocks making the biggest moves midday: Teva Pharmaceuticals, Hilton, Groupon & moreThese are the stocks posting the largest moves midday Wednesday.
Read more »

Teva stock tumbles premarket as earnings and guidance fall short of estimates
Read more »

Teva expects about 25 percent of EpiPen market by year-endTeva Pharmaceutical Industries expects its generic version of Mylan's EpiPe...
Read more »

A US-China trade deal may not be the catalyst the market is expectingMarket strategists and policymakers are putting too much emphasis on a trade deal between the United States and China, and it's quite likely that whatever is agreed will disappoint.
Read more »

Markets Right Now: Weak sales report sinks US stock prices
Read more »

Trump expected to issue new order laying groundwork to bar Chinese tech firms from U.S. networksIt would give the commerce secretary power to stop U.S. companies from doing business with foreign suppliers such as Huawei.
Read more »